logo

For the Inventor, By the Inventor

Stockholm, Sweden

Pharmacia & Upjohn Aktiebolag


USPTO Granted Patents = 47


Trademarks = 1

Forward Citations = 1,608

Loading Chart...
Loading Chart...

84 inventors (with patents filed for the assignee):

goldMedal Birger Hjertman (7 out of 43 patents)

silverMedal Johan W Stjernschantz (4 out of 28 patents)

bronzeMedal Gert A Ragnarsson (4 out of 7 patents)

4.  Robert T Lyons (3 out of 30 patents)

5.  Birgitta Olsson (3 out of 7 patents)

6.  Maritta Anneli Pesonen (3 out of 3 patents)

7.  Thomas Osterberg (3 out of 6 patents)

8.  Ebba Florin-Robertsson (2 out of 11 patents)

9.  Peter David Gluckman (2 out of 29 patents)

10.  Bahram Resul (2 out of 23 patents)

11.  Erik Holmgren (2 out of 6 patents)

12.  Mats Lake (2 out of 6 patents)

13.  Staffan Lake (2 out of 3 patents)

14.  Bjorn Nilsson (2 out of 5 patents)

15.  Olle Ljungquist (2 out of 12 patents)


Core Competencies:
Prostaglandin Derivatives
Heparin Derivatives
Controlled Release Preparation
Injection Devices
Oligopeptides
Cell Cultivation
Apolipoprotein
Growth Hormone
Fluid Distribution System
Pharmaceutical Composition
Emulsion Lubricant
Antitumour Agents

47 patents:

1. 6416972 - DNA encoding a prostaglandin F2&agr; receptor, a host cell transformed therewith and an expression product thereof (2002-07-09),
2. RE37286 - Method of cleansing a protein from multivalent metal ions bound thereto (2001-07-17),
3. 6187813 - Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension (2001-02-13),
4. 6150342 - Heparin derivatives for treatment of angina pectoris (2000-11-21),
5. 6054421 - Medical emulsion lubricant (2000-04-25),
6. 6042571 - Injection device (2000-03-28),
7. 6030999 - Prostaglandin derivatives for the treatment of glaucoma or ocular (2000-02-29),
8. 6004298 - Injection devices (1999-12-21),
9. 5972885 - Method for treatment of hemophilia by extravascular administration of (1999-10-26),
10. 5962650 - Oxygen-reduced aqueous solution of factor VIII (1999-10-05),
11. 5952005 - Controlled release preparation for administering morphine (1999-09-14),
12. 5919766 - Composition comprising coagulation factor VIII formulation, process for (1999-07-06),
13. 5902788 - Insulin-like growth factor II as antitumour agent (1999-05-11),
14. 5888815 - Cell cultivation method and medium (1999-03-30),
15. 5880098 - Therapeutic treatment (1999-03-09),
Pharmacia & Upjohn Aktiebolag is a multinational pharmaceutical company that focuses on research, development, manufacturing, and marketing of prescription medicines and vaccines. With a commitment to improving global health, Pharmacia & Upjohn actively works towards bringing innovative therapeutic solutions to patients worldwide. They aim to address unmet medical needs and improve the quality of life for individuals with various health conditions. For more information, please visit their official website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

47 Patents

#24 in Stockholm

#142 in Sweden

#14,414 in the World

...
Stockholm, Sweden

Pharmacia & Upjohn Aktiebolag

Forward Citations = 1,608

84 inventors:

goldMedal Birger Hjertman (7 out of 43 patents)

silverMedal Johan W Stjernschantz (4 out of 28 patents)

bronzeMedal Gert A Ragnarsson (4 out of 7 patents)

4.  Robert T Lyons (3 out of 30 patents)

5.  Birgitta Olsson (3 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…